source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[individual]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	Technology type	assay name	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-1	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_05	QEHF_170807_05.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_05.raw	1	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-2	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_06	QEHF_170807_06.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_06.raw	2	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-3	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_07	QEHF_170807_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_07.raw	3	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-4	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_08	QEHF_170807_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_08.raw	4	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-5	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_09	QEHF_170807_09.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_09.raw	5	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-6	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_10	QEHF_170807_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_10.raw	6	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-7	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_11	QEHF_170807_11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_11.raw	7	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-8	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_12	QEHF_170807_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_12.raw	8	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-9	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_13	QEHF_170807_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_13.raw	9	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-10	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_14	QEHF_170807_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_14.raw	10	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-11	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_15	QEHF_170807_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_15.raw	11	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-12	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_16	QEHF_170807_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_16.raw	12	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-13	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_17	QEHF_170807_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_17.raw	13	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-14	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_18	QEHF_170807_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_18.raw	14	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-15	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_19	QEHF_170807_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_19.raw	15	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-16	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_20	QEHF_170807_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_20.raw	16	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-17	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_21	QEHF_170807_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_21.raw	17	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-18	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_22	QEHF_170807_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_22.raw	18	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-19	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_23	QEHF_170807_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_23.raw	19	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	1	not applicable	no available	no available	not applicable	normal	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	2	not applicable	no available	no available	not applicable	normal	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	3	not applicable	no available	no available	not applicable	normal	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	4	not applicable	no available	no available	not applicable	normal	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	5	not applicable	no available	no available	not applicable	normal	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	131	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	6	not applicable	no available	no available	not applicable	preeclampsia	no depletion	1	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	128N	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	7	not applicable	no available	no available	not applicable	preeclampsia	no depletion	2	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	129C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	8	not applicable	no available	no available	not applicable	preeclampsia	no depletion	3	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	130C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	9	not applicable	no available	no available	not applicable	preeclampsia	no depletion	4	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	126	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
PXD010364-Sample-20	Homo sapiens	blood	AC=CL:0000232; NT=erythrocyte	10	not applicable	no available	no available	not applicable	preeclampsia	no depletion	5	proteomic profiling by mass spectrometry	QEHF_170807_24	QEHF_170807_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/06/PXD010364/QEHF_170807_24.raw	20	AC=PRIDE:0000563; NT=Reversed-phase chromatography	127C	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	5 ppm	200 mmu	AC=CL:0000232; NT=erythrocyte
